Excellere Completes MTS Medication Buyout

Excellere Partners has completed its acquisition of MTS Medication Technologies Inc. (Nasdaq: MTSI), a provider of medication adherence packaging systems. The deal was valued at approximately $37 million, or $5.75 per share. Raymond James & Associates served as MTS' financial advisor.

DealsNorth AmericaUSBriefs